Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Kristian Helin
Affiliation
The Institute of Cancer Research
ORCID
Career Start Year
1988
Papers
275
H Index
105
Expertise
CM4AI Collaborator
Antoine Forget (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36631623
The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes.
Leukemia
2023
37907651
Author Correction: H3K4me3 regulates RNA polymerase II promoter-proximal pause-release.
Nature
2023
37845773
Vitamin C activates young LINE-1 elements in mouse embryonic stem cells via H3K9me3 demethylation.
Epigenetics Chromatin
2023
37987160
An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions.
EMBO J
2023
37024580
Catching active enhancers via H2B N-terminal acetylation.
Nat Genet
2023
37436979
An organoid-based CRISPR-Cas9 screen for regulators of intestinal epithelial maturation and cell fate.
Sci Adv
2023
37402365
Chromatin regulation of transcriptional enhancers and cell fate by the Sotos syndrome gene NSD1.
Mol Cell
2023
37369835
EZH2i unlocks PDAC immune surveillance.
Nat Cancer
2023
36959757
PR-DUB safeguards Polycomb repression through H2AK119ub1 restriction.
Cell Prolif
2023
36859550
H3K4me3 regulates RNA polymerase II promoter-proximal pause-release.
Nature
2023
36941349
Publisher Correction: H3K4me3 regulates RNA polymerase II promoter-proximal pause-release.
Nature
2023
34359076
Targeting RIOK2 ATPase activity leads to decreased protein synthesis and cell death in acute myeloid leukemia.
Blood
2022
35349793
Chromatin modifier HUSH co-operates with RNA decay factor NEXT to restrict transposable element expression.
Mol Cell
2022
35668298
Histone editing elucidates the functional roles of H3K27 methylation and acetylation in mammals.
Nat Genet
2022
35421216
BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation.
Blood
2022
35862399
Correction: A Screen Identifies the Oncogenic Micro-RNA miR-378a-5p as a Negative Regulator of Oncogene-Induced Senescence.
PLoS One
2022
35302840
H3K9 dimethylation safeguards cancer cells against activation of the interferon pathway.
Sci Adv
2022
35202573
CpG island reconfiguration for the establishment and synchronization of polycomb functions upon exit from naive pluripotency.
Mol Cell
2022
34582804
SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling.
Cell Stem Cell
2022
34031396
MPP8 is essential for sustaining self-renewal of ground-state pluripotent stem cells.
Nat Commun
2021
33657400
Complex-dependent histone acetyltransferase activity of KAT8 determines its role in transcription and cellular homeostasis.
Mol Cell
2021
34667079
PROSER1 mediates TET2 O-GlcNAcylation to regulate DNA demethylation on UTX-dependent enhancers and CpG islands.
Life Sci Alliance
2021
34663818
TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis.
Nat Commun
2021
34848497
The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity.
Cancer Immunol Res
2021
34151298
Generation of locus-specific degradable tag knock-ins in mouse and human cell lines.
STAR Protoc
2021
34009619
ChIP-Sequencing of TET Proteins.
Methods Mol Biol
2021
31518438
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers.
J Pathol
2020
31896750
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary.
Nat Commun
2020
32747411
PR-DUB maintains the expression of critical genes through FOXK1/2- and ASXL1/2/3-dependent recruitment to chromatin and H2AK119ub1 deubiquitination.
Genome Res
2020
32669286
PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2<sup>V617F</sup>-Mutant MPN.
Cancer Discov
2020
32641411
Mutant FOXL2<sup>C134W</sup> Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.
Cancer Res
2020
32231309
KDM4A regulates the maternal-to-zygotic transition by protecting broad H3K4me3 domains from H3K9me3 invasion in oocytes.
Nat Cell Biol
2020
30538297
HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases.
Oncogene
2019
31722198
A Functional Link between Nuclear RNA Decay and Transcriptional Control Mediated by the Polycomb Repressive Complex 2.
Cell Rep
2019
31691806
Histone demethylase KDM5C is a SAHA-sensitive central hub at the crossroads of transcriptional axes involved in multiple neurodevelopmental disorders.
Hum Mol Genet
2019
30076673
The histone demethylase Jarid1b mediates angiotensin II-induced endothelial dysfunction by controlling the 3'UTR of soluble epoxide hydrolase.
Acta Physiol (Oxf)
2019
31611688
PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia.
Nat Struct Mol Biol
2019
31467927
The Lysine Demethylase KDM5B Regulates Islet Function and Glucose Homeostasis.
J Diabetes Res
2019
31434704
The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance.
Blood
2019
31521506
Non-core Subunits of the PRC2 Complex Are Collectively Required for Its Target-Site Specificity.
Mol Cell
2019
31311845
Correction for Danovi et al., "Amplification of <i>Mdmx</i> (or <i>Mdm4</i>) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor Activity".
Mol Cell Biol
2019
30951652
Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation.
Mol Cell
2019
30917958
The chromatin-binding protein Phf6 restricts the self-renewal of hematopoietic stem cells.
Blood
2019
30796038
TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells.
Genome Res
2019
30672466
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells.
Elife
2019
29650963
Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation.
Nat Commun
2018
29844126
The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.
Cancer Res
2018
30526604
Aggressiveness of non-EMT breast cancer cells relies on FBXO11 activity.
Mol Cancer
2018
29483650
Accurate H3K27 methylation can be established de novo by SUZ12-directed PRC2.
Nat Struct Mol Biol
2018
28694333
EPC1/TIP60-Mediated Histone Acetylation Facilitates Spermiogenesis in Mice.
Mol Cell Biol
2017
1 - 50 of 275
Column Actions
Search
Recommended Authors
Greg Donahue
Penn Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania
Career Start Year
2010
Number of shared co-authors
1
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Career Start Year
2010
Number of shared co-authors
0
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
1
Diana Low
Institute of Molecular and Cell Biology (IMCB)
Career Start Year
2005
Number of shared co-authors
1
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
4
Hanneke E C Niessen
Maastricht University Medical Center
Career Start Year
2005
Number of shared co-authors
0
Etienne Danis
University of Colorado Anschutz Medical Campus
Career Start Year
2004
Number of shared co-authors
1
Michele Ceribelli
National Center for Advancing Translational Sciences
Career Start Year
2004
Number of shared co-authors
1
Stefan Kubicek
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year
2003
Number of shared co-authors
4
Ernesto Guccione
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year
2001
Number of shared co-authors
3
SiDe Li
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year
1999
Number of shared co-authors
0
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year
1999
Number of shared co-authors
21
Joyce E Ohm
Roswell Park Comprehensive Cancer Center
Career Start Year
1999
Number of shared co-authors
0
Aaron Aslanian
Salk Institute for Biological Studies
Career Start Year
1998
Number of shared co-authors
2
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1997
Number of shared co-authors
2
Peter C Scacheri
Case Western Reserve University School of Medicine
Career Start Year
1995
Number of shared co-authors
13
Sanja Pajovic
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Career Start Year
1993
Number of shared co-authors
0
Julien Sage
Department of Pediatrics Stanford University Stanford California USA.
Career Start Year
1993
Number of shared co-authors
2
Jan Willem Voncken
Maastricht University
Career Start Year
1992
Number of shared co-authors
0
Peter D Adams
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1991
Number of shared co-authors
1
Ali Shilatifard
Northwestern University Feinberg School of Medicine
Career Start Year
1991
Number of shared co-authors
4
Alex Vassilev
National Institute of Child Health & Human Development, National Institutes of Health
Career Start Year
1991
Number of shared co-authors
0
Dirk Geerts
Amsterdam University Medical Center
Career Start Year
1989
Number of shared co-authors
1
Martin J Walsh
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year
1987
Number of shared co-authors
0
Joseph Torchia
Western University
Career Start Year
1985
Number of shared co-authors
0
Kornel E Schuebel
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health
Career Start Year
1985
Number of shared co-authors
0
Shelley L Berger
Penn Epigenetics Institute, Perelman School of Medicine
Career Start Year
1985
Number of shared co-authors
2
Ralf Kittler
McDermott Center for Human Growth and Development.
Career Start Year
1984
Number of shared co-authors
2
Stephen J Elledge
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1982
Number of shared co-authors
3
Peggy J Farnham
Keck School of Medicine of USC
Career Start Year
1978
Number of shared co-authors
12
row(s) 1 - 30 of 30
Collaborators
Diego Pasini
European Institute of Oncology IRCCS
Co-authored papers
27
Adrian P Bracken
Smurfit Institute of Genetics, Trinity College Dublin
Co-authored papers
17
Ole N Jensen
VILLUM Center for Bioanalytical Sciences, University of Southern Denmark
Co-authored papers
17
Juri Rappsilber
Institute for Biotechnology, Technical University Berlin
Co-authored papers
10
Simone Sidoli
Co-authored papers
9
Richard Koche
Memorial Sloan Kettering Cancer Center
Co-authored papers
7
Ronald C Hendrickson
Memorial Sloan Kettering Cancer Center
Co-authored papers
5
Haruhiko Koseki
RIKEN Research Center for Allergy and Immunology
Co-authored papers
4
Frederik Otzen Bagger
Center for Genomic Medicine, Rigshospitalet Copenhagen University Hospital
Co-authored papers
4
Albin Sandelin
University of Copenhagen
Co-authored papers
3
Veit Schw??mmle
University of Southern Denmark
Co-authored papers
3
Atsushi Iwama
Co-authored papers
3
Dominique Leprince
University Lille, CNRS, INSERM
Co-authored papers
2
Marc Vidal
Blavatnik Institute, Harvard Medical School
Co-authored papers
2
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Sriganesh Jammula
Early Cancer Institute, Hutchison Research Centre, University of Cambridge
Co-authored papers
2
Alex Look
Dana-Farber Cancer Institute
Co-authored papers
2
Robert A Soslow
Co-authored papers
2
Harmen J G van de Werken
Department of Immunology Erasmus University Medical Center
Co-authored papers
2
Torben Heick Jensen
Universitetsbyen 81, Aarhus University
Co-authored papers
2
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Douglas R Lowy
Co-authored papers
2
Mette J??rgensen
University of Copenhagen
Co-authored papers
2
Edith Heard
Institut Curie, PSL Research University, CNRS UMR 5, INSERM U934
Co-authored papers
2
Jakob Skou Pedersen
Co-authored papers
2
Nicolas Rapin
Rigshospitalet, University of Copenhagen
Co-authored papers
2
Andrea Scelfo
Institut Curie, PSL Research University, CNRS
Co-authored papers
2
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers
2
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers
2
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
1
1 - 30